ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

JPMORGAN CHASE & CO's Holding History (CIK: 0000019617)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 20,701 Value ($000) $319 Avg Close $19.92 Range $15.14 - $24.64
Q3 2025
Shares 24,818 Value ($000) $508 Avg Close $20.16 Range $17.43 - $24.38
Q2 2025
Shares 19,064 Value ($000) $382 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 21,765 Value ($000) $428 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 19,745 Value ($000) $444 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 20,807 Value ($000) $531 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 20,794 Value ($000) $486 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 18,387 Value ($000) $323 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 23,989 Value ($000) $332 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 26,495 Value ($000) $362 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 30,655 Value ($000) $626 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 94 Value ($000) $2 Avg Close $20.34 Range $14.56 - $25.34